Agriculture America army China Donald Trump Economy Europe European Finance Germany Healthcare Investment Manufacturing Medicine military NATO Pharmaceutical Revenue Senate Tariff Ukraine United Kingdom United States USA War
US TROOP MOVEMENTS IN EUROPE NOT ‘PUNITIVE,’ RUBIO SAYS AFTER POLAND REVERSAL For decades, Germany and other wealthy European countries have maintained strict government controls on drug prices. Their citizens pay far less for many lifesaving medicines than Americans do — and are only able to because Americans are responsible for an outsize share of the costs of innovation. The U.S. accounts for a massive, disproportionate share of pharmaceutical investment, innovation, and revenue. That revenue finances the risky and extraordinarily expensive process of developing new treatments for cancer, rare diseases, Alzheimer’s, and countless other conditions. Most experimental drugs fail. Companies…
News Timeline:
Track the development of this news story across the Internet.